Cationic Lipid–Nucleic Acid Complexes for Gene Delivery and Silencing: Pathways and Mechanisms for Plasmid DNA and siRNA

Purpose: Cationic lipid–nucleic acid (CL-NA) complexes are promising non-viral vectors for gene delivery and siRNA-mediated silencing, but their transfection and silencing efficiencies remain low compared with viral vectors. A major gap is poor mechanistic understanding of how complex structure, membrane charge density, and lipid composition govern cellular pathways and biological activity.

Hypothesis: The central thesis is that the transfection efficiency (TE) of lamellar CL-DNA complexes is universally governed by membrane charge density (σ_M), while non-lamellar structures and specific helper lipids (e.g., cholesterol) can bypass or shift this behavior. For CL-siRNA complexes, multivalent cationic lipids are expected to improve silencing efficiency while reducing toxicity compared with monovalent lipids.

Aims: Review recent efforts to correlate the structures, chemical and biophysical properties of CL-NA complexes with their biological activity. - Describe distinct nanoscale structures of CL-DNA complexes and their effects on transfection mechanisms. - Identify membrane charge density as a universal parameter for lamellar CL-DNA transfection and explain the role of cholesterol and analogs. - Evaluate highly charged dendritic multivalent lipids for DNA delivery and hard-to-transfect cells. - Compare monovalent and multivalent cationic lipids for siRNA delivery, silencing efficiency, and cytotoxicity. - Discuss future directions for in vivo non-viral vector design.

Delivery system: Platform: Cationic lipid–nucleic acid complexes (lipoplexes) for plasmid DNA delivery and siRNA-mediated gene silencing. - Key materials: Cationic lipids including DOTAP (monovalent), MVL2–MVL5 (multivalent, +2 to +5), TMVL5, and dendritic lipids (MVLG2, MVLG3, MVLBisG1, MVLBisG2; up to +16). Helper/neutral lipids: DOPC, DOPE, cholesterol, and cholesterol analogs. - Payloads: Plasmid DNA and short interfering RNA (siRNA; 19–27 bp dsRNA with 2-nt 3′ overhangs). - Structures formed: Lamellar (L_α^C), inverted hexagonal (H_II^C), hexagonal (H_I^C), distorted hexagonal, and DNA bundle phases. - Targeting: No active targeting ligand in this review; PEGylation and targeting ligands discussed as future in vivo strategies.

Approach: Type of study: Review of primary work from the authors’ laboratory, combining custom lipid synthesis, synchrotron X-ray diffraction (XRD), cryo-TEM, optical/confocal microscopy, and biological assays. - In vitro models: Mouse fibroblast cells, mouse L-cells, HeLa cells, mouse embryonic fibroblasts (MEFs), human 293 cells. - Key variables: Cationic lipid valence and headgroup structure; molar fraction of cationic lipid; neutral lipid identity (DOPC, DOPE, cholesterol, analogs); cationic lipid/DNA or siRNA charge ratio (ρ_chg). - Readouts: Transfection efficiency (luciferase expression, RLU/mg protein); gene silencing (total knockdown K_T and non-specific knockdown K_NS); cytotoxicity (LDH release, cell viability).

Key methods: Synchrotron X-ray diffraction (XRD) to determine nanoscale structures and membrane charge density. - Cryo-TEM and optical microscopy for complex morphology and block liposome structures. - Confocal microscopy for cellular uptake and intracellular pathways. - Luciferase transfection assays for TE. - Dual luciferase assay to separate target-specific knockdown (K_T) from non-specific cytotoxicity-related knockdown (K_NS). - Zeta potential and ethidium bromide displacement for effective headgroup charge.

Key results: For lamellar CL-DNA complexes, TE follows a universal bell-shaped curve as a function of membrane charge density, with an optimal σ_M ≈ 17.0 × 10⁻³ e/Ų. Data for monovalent and multivalent lipids collapse onto this curve. - Adding 15 mol% cholesterol to low-transfecting DOTAP/DOPC-DNA complexes increases TE by a factor of 10; further cholesterol continues to increase TE. This enhancement is attributed to reduced hydration repulsion, not solely increased σ_M. - Dendritic lipid MVLBisG2 (+16) forms non-lamellar phases and efficiently transfects mouse embryonic fibroblasts (MEFs), a hard-to-transfect cell line, surpassing DOTAP. - For siRNA delivery, MVL5/DOPC-siRNA complexes achieve K_T ≈ 0.9 with K_NS < 0.1, whereas DOTAP/DOPC-siRNA complexes show lower specific silencing and higher non-specific toxicity. DOTAP/DOPE-siRNA complexes are notably toxic.

Interpretation: The authors argue that understanding structure–function relationships—especially membrane charge density, complex phase, and helper lipid properties—can enable rational design of more efficient and less toxic non-viral vectors. Multivalent and dendritic lipids are particularly promising for siRNA delivery and hard-to-transfect cells, and cholesterol-like helper lipids can enhance endosomal escape by reducing hydration repulsion.

Limitations: This is a review, not a primary research article; no new experimental data are presented. - Most mechanistic and transfection data are from in vitro cell culture; in vivo barriers (serum stability, clearance, targeting) remain major challenges. - The universal TE curve applies primarily to lamellar CL-DNA complexes; non-lamellar structures and CL-siRNA complexes deviate. - Cytotoxicity and non-specific silencing are still limiting for some lipid compositions, especially DOTAP/DOPE. - Clinical translation is not demonstrated; PEGylation and targeting strategies are discussed but not optimized in this work.